Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-7,550
Closed -$2.14M 1408
2025
Q1
$2.35M Buy
+7,550
New +$2.23M 0.02% 638
2023
Q3
Sell
-21,912
Closed -$4.86M 1256
2023
Q2
$4.86M Buy
+21,912
New +$5.08M 0.09% 294
2023
Q1
Sell
-3,900
Closed -$1.02M 1059
2022
Q4
$1.02M Buy
3,900
+2,300
+144% +$617K 0.02% 743
2022
Q3
$361K Sell
1,600
-31,587
-95% -$7.66M 0.01% 1137
2022
Q2
$8.07M Buy
+33,187
New +$8.13M 0.11% 233
2021
Q3
Sell
-2
Closed 1483
2021
Q2
$0 Sell
2
-94,998
-100% -$23.4M ﹤0.01% 1269
2021
Q1
$23.6M Buy
+95,000
New +$22.7M 0.51% 29

Other funds holding AMGN

Caption Management's AMGN Position: Q2 2025 in Review

Caption Management sold out of Amgen (AMGN) in Q2 2025, closing a stake of 7,550 shares — an estimated $2.14M sold.

Caption Management first reported a position in AMGN in Q1 2021 and held it in 7 quarters. The position peaked at $23.6M in Q1 2021. 2,852 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Caption Management reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
  • Caption Management sold 7,550 Amgen shares in Q2 2025, an estimated $2.14M.
  • Caption Management first reported a position in Amgen in Q1 2021 and held it in 7 quarters.
  • Caption Management's Amgen position peaked at $23.6M in Q1 2021.
  • 2,852 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.